Global post-marketing safety surveillance of Tumor Treating Fields（TTFields） in patients with high-grade glioma in clinical practice

Shi W, et al.: J Neurooncol. 2020 Jul;148（3）:489-500. doi: 10.1007/s11060-020-03540-6. Epub 2020 Jun 13.

Health-Related Quality of Life for Patients Receiving Tumor Treating Fields for Glioblastoma

Palmer JD, et al.: Front Oncol. 2021 Dec 2;11:772261. doi: 10.3389/fonc.2021.772261. eCollection 2021.